● LIVE
Updated 2h ago
· 16 sources tracked
Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial
A secondary analysis of the S-LiTE trial found that exercise reduces carotid intima-media thickness and systemic pro-inflammatory cytokine levels in adults with obesity. Liraglutide alone did not produce these improvements. Combination treatment further enhanced endothelial function biomarkers.
What changed
New data from the S-LiTE trial differentiates the vascular benefits of exercise from those of liraglutide.
Live updates
-
Exercise Drives Vascular Gains Over Liraglutide Alone in S-LiTE Trial
confidence 100%A secondary analysis of the S-LiTE trial found that exercise reduces carotid intima-media thickness and systemic pro-inflammatory cytokine levels in adults with obesity. Liraglutide alone did not produce these improvements. Combination treatment further enhanced endothelial function biomarkers.
What's confirmed:
- The S-LiTE trial involved 130 adults with obesity who completed a diet-induced weight loss plan before randomization to 52 weeks of weight maintenance with exercise and/or liraglutide.
- Exercise, whether alone or combined with liraglutide, reduces systemic pro-inflammatory cytokine levels including interferon-gamma and interleukin-6.
- Regular physical activity reduces carotid intima-media thickness in adults with obesity during weight loss maintenance.
- Liraglutide alone does not reduce vascular thickness or inflammation markers.
- Combination treatment of exercise and liraglutide improves endothelial function biomarkers sVCAM-1, sICAM-1, and tPA.
- Copenhagen University researchers published these findings in Nature Metabolism on June 24.